The long-term efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine in patients with medication overuse: results of the COMPEL study

被引：0
|
作者：
Tepper, S. [1 ]
Wilson, M. -C. [2 ]
Orejudos, A. [3 ]
Adams, A. Manack [3 ]
Blumenfeld, A. [4 ]
机构：
[1] Geisel Sch Med Dartmouth, Hanover, NH USA
[2] Ochsner Hlth Syst, Covington, LA USA
[3] Allergan Plc, Irvine, CA USA
[4] Headache Ctr Southern Calif, Neurol Cente, Carlsbad, CA USA
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2018年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O404
引用
收藏
页码：78 / 78
页数：1
相关论文
共 50 条
  • [21] Long-Term term efficacy of fremanezumab in chronic and episodic migraine patients with acute medication overuse at baseline: results of a 1-year study
    Silberstein, Stephen D.
    Ashina, Messoud
    Cohen, Joshua M.
    Seminerio, Michael J.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    CEPHALALGIA, 2019, 39 : 234 - 235
  • [22] Onabotulinumtoxin A for Chronic Migraine with Medication Overuse: clinical results of a long-term treatment
    Grazzi, Licia
    Andrasik, Frank
    D'Amico, Domenico
    Leonardi, Matilde
    Raggi, Alberto
    Sansone, Emanuela
    CEPHALALGIA, 2017, 37 : 90 - 91
  • [23] Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment
    Licia Grazzi
    Neurological Sciences, 2017, 38 : 141 - 143
  • [24] Onabotulinumtoxin A for chronic migraine with medication overuse: clinical results of a long-term treatment
    Grazzi, Licia
    NEUROLOGICAL SCIENCES, 2017, 38 : S141 - S143
  • [25] P045. OnabotulinumtoxinA: long term treatment for chronic migraine with medication overuse
    Simona Guerzoni
    Maria Michela Cainazzo
    Luigi Alberto Pini
    The Journal of Headache and Pain, 2015, 16
  • [26] Long-term Treatment Benifits and Prolonged Efficacy of OnabotulinumtoxinA in Patients Affected by Chronic Migraine and Medication Overuse Headache over 3 Years of Therapy
    Guerzoni, Simona
    Pellesi, Lanfranco
    Baraldi, Carlo
    Cainazzo, Michela Maria
    Negro, Andrea
    Martelletti, Paolo
    Pini, Luigi Alberto
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [27] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study
    Silberstein, Stephen D.
    Ashina, Messoud
    Cohen, Joshua M.
    Seminerio, Michael J.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    ANNALS OF NEUROLOGY, 2019, 86 : S76 - S76
  • [28] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients with Acute Medication Overuse at Baseline: Results of a 1-Year Study
    Silberstein, S. D.
    Ashina, M.
    Cohen, J. M.
    Seminerio, M. J.
    Yang, R.
    Ning, X.
    HEADACHE, 2019, 59 : 95 - 96
  • [29] Rationale for Study and Design of COMPEL: An Open-Label, Multicenter Study of the Long-Term Efficacy, Safety, and Tolerability of OnabotulinumtoxinA for Headache Prophylaxis in Adults with Chronic Migraine
    Blumenfeld, A. M.
    Aurora, S. K.
    Laranjo, K.
    Varon, S. F.
    Papapetropoulos, S.
    HEADACHE, 2012, 52 (05): : 881 - 881
  • [30] Long-term efficacy of erenumab in chronic migraine (CM) patients with or without acute medication overuse (AMO)
    Tepper, Stewart
    Lipton, Richard
    Silberstein, Stephen
    Kudrow, David
    Ashina, Messoud
    Reuter, Uwe
    Dodick, David
    Zhang, Feng
    Cheng, Sunfa
    Mikol, Daniel
    NEUROLOGY, 2020, 94 (15)
12345